click to expand
Imagine having tiny electronics implanted somewhere in your
body that can regulate nerve signals and make symptoms of various disorders go
away. That’s the vision of the field of bioelectronic medicine — the emerging
discipline that has made enough promising advances to draw a big investment by
a pharmaceutical giant, according to an article in Chemical & Engineering
News (C&EN), the weekly news magazine of the American Chemical Society.